Abstract
The immediate impact of rapid glucose lowering induced by bariatric surgery on diabetic retinopathy (DR) progression remains unclear. We present 3-year changes in the best-corrected visual acuity and DR grade in a retrospective observational study of 32 morbidly obese patients (64 eyes) who underwent Roux-en-Y-gastric bypass surgery. We found that despite overall benefits in vision, there was an initial progression from no retinopathy to background retinopathy in 18.9% and 21.7% at years 1 and 2 respectively. Patients with pre-proliferative DR at baseline were at increased risk of developing sight-threatening DR. We recommend that patients with diabetes undergoing bariatric surgery have a baseline visual acuity, macular optical coherent tomography and diabetic retinopathy grading from wide-field digital imaging to identify those at risk of sight-threatening diabetic retinopathy.
References
Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122(3):248–256. e5.
National Institute For Health and Clinical Excellence (NICE). Obesity: identification, assessment and management (CG189). 2014. Available from https://www.nice.org.uk/guidance/cg189/resources/obesity-identification-assessment-and-management-pdf-35109821097925. Accessed 10 June 2018.
Murphy R, Jiang Y, Booth M, et al. Progression of diabetic retinopathy after bariatric surgery. Diabet Med. 2015;32(9):1212–20.
Merlotti C, Ceriani V, Morabito A, et al. Bariatric surgery and diabetic retinopathy: a systematic review and meta-analysis of controlled clinical studies. Obes Rev. 2017;18:309–16.
Coleman KJ, Haneuse S, Johnson E, et al. Long-term microvascular disease outcomes in patients with type 2 diabetes after bariatric surgery: evidence for the legacy effect of surgery. Diabetes Care. 2016;39:1400–7.
Feldman-Billard S, Larger É, Massin P, et al. Early worsening of diabetic retinopathy after rapid improvement of blood glucose control in patients with diabetes. Diabetes Metab. 2018;44:4–14.
Marso SP, Bain SC, Consoli A, et al. Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med. 2016;375(19):1834–44.
Vilsboll T, Bain SC, Leiter LA, et al. Semaglutide, reduction in glycated haemoglobin and the risk of diabetic retinopathy. Diabetes Obes Metab. 2018;20:889–97.
Davis MD, Beck RW, Home PD, et al. Early retinopathy progression in four randomized trials comparing insulin glargine and NPH [corrected] insulin. Exp Clin Endocrinol Diabetes. 2007;115(4):240–3.
Rosenstock J, Fonseca V, McGill JB, et al. Similar progression of diabetic retinopathy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: a long-term, randomised, open-label study. Diabetologia. 2009;52(9):1778–88.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Informed Consent
Not applicable. This was a retrospective evaluation of routine clinical practice. For this type of study, formal consent is not required.
Human and Animal Rights
This was a retrospective evaluation of routine clinical practice. Data collection was performed in accordance with the ethical standards of the Derby Teaching Hospitals NHS Trust.
Rights and permissions
About this article
Cite this article
Richardson, P., Hulpus, A. & Idris, I. Short-Term Impact of Bariatric Surgery on Best-Corrected Distance Visual Acuity and Diabetic Retinopathy Progression. OBES SURG 28, 3711–3713 (2018). https://doi.org/10.1007/s11695-018-3445-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-018-3445-z